| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959366 | Journal of the American College of Cardiology | 2005 | 6 Pages |
Abstract
High post-treatment platelet reactivity and incomplete P2Y12receptor inhibition are risk factors for SAT. Measures to uniformly determine platelet reactivity after coronary stenting and treatment strategies to improve P2Y12receptor inhibition in patients with high post-treatment platelet reactivity should be further investigated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul A. (FACC), Kevin P. BS, Waiel MD, Jason A. MD, Kevin MD, Mulugeta Z. MD, Udaya S. PhD,